Watanabe A, Watanabe T, Tabata T, Takahashi K, Abe T, Abe S, Sato M, Kusajima K
Department of Cardio-Thoracic Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan.
Kyobu Geka. 2001 Oct;54(11):917-20.
We evaluated the relationship between Noguchi's classification for small adenocarcinomas of the lung and tumor markers in serum (CEA, Cyfra, SLX, CA 19-9, CA 125). Fifty surgically resected small peripheral adenocarcinomas measuring 2 cm or less in greatest diameter were examined. The tumors were divided into three groups on the basis of Noguchi's classification: group AB of tumors belonging to Noguchi's classification A or B, group C of tumors belonging to Noguchi's classification C, and group DEF of tumors belonging to Noguchi's classification D, E, or F. The level of serum CEA was higher in group DEF (5.9 +/- 7.6 ng/ml) than in group AB (2.3 +/- 2.4 ng/ml) and group C (2.0 +/- 1.3 ng/ml). There were no differences in the levels of the other serum tumor markers among the three groups. The incidences of anormality in serum CEA and Cyfra were higher in group DEF (6/18 and 6/18, respectively) than in group AB (1/7 and 0/7) and group C (1/25 and 1/25). Although a high level of serum CEA or Cyfra is a strong indication that the tumor is Noguchi's classification D, E, or F of pulmonary adenocarcinoma, it is difficult to classify small adenocarcinomas by Noguchi's classification using a serum tumor marker level.
我们评估了肺小腺癌的野口分类与血清肿瘤标志物(癌胚抗原、细胞角蛋白片段、鳞状上皮细胞癌抗原、糖类抗原19-9、糖类抗原125)之间的关系。对50例手术切除的最大直径为2厘米或更小的小周边腺癌进行了检查。根据野口分类,肿瘤被分为三组:属于野口分类A或B的肿瘤AB组,属于野口分类C的肿瘤C组,以及属于野口分类D、E或F的肿瘤DEF组。DEF组血清癌胚抗原水平(5.9±7.6纳克/毫升)高于AB组(2.3±2.4纳克/毫升)和C组(2.0±1.3纳克/毫升)。三组中其他血清肿瘤标志物水平无差异。DEF组血清癌胚抗原和细胞角蛋白片段异常发生率(分别为6/18和6/18)高于AB组(1/7和0/7)和C组(1/25和1/25)。虽然血清癌胚抗原或细胞角蛋白片段水平升高强烈提示肿瘤为肺腺癌野口分类D、E或F,但使用血清肿瘤标志物水平按野口分类对小腺癌进行分类是困难的。